The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms by which tumor cells achieve an enhanced glycolytic flux and, presumably, a decreased oxidative phosphorylation are analyzed. As the O 2 concentration in hypoxic regions of tumors seems not limiting for oxidative phosphorylation, the role of this mitochondrial pathway in the ATP supply is re‐evaluated. Drugs that inhibit glycoysis and oxidative phosphorylation are analyzed for their specificity toward tumor cells and effect on proliferation. The energy metabolism mechanisms involved in the use of positron emission tomography are revised and updated. It is proposed that energy metabolism may be an alternative therapeutic target for both hypoxic (glycolytic) and oxidative tumors. © 2009 International Union of Biochemistry and Molecular Biology, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 2×
“As a consequence, it has been proposed that PDH inactivation ocurrs in cancer cells, which leads to decreased pyruvate oxidation through the Krebs cycle and decreased mitochondrial oxygen consumption [32,33].”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337 · cited 2×
“Some authors have proposed that this p53 inactivation provides a metabolic shift from respiratory to glycolytic metabolism although, in accord with the TIGAR observations, it would rather favor mitochondrial oxidative metabolism [76].”
ResultHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 2×
“Low expression and activity of OxPhos enzymes and transporters Krebs cycle enzymes Transformed mesenchymal cells, phaeochromocytomas, paragangliomas, liomyomas, leiomyosarcomas, renal cell, gastric and colon carcinomas, and papillary thyroid cancer [2,18,21–24]”
BackgroundTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 2×
“The tumor suppressor p53 activates TIGAR, a PFK-2 isoform that generates low F2,6BP levels, and hence unfavors glycolysis [72].”
BackgroundHypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 2×
“Moreover, p53 upregulates the COX subunit II protein expression [73], and down-regulates mRNA and protein expression of PGAM [74].”
BackgroundFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 2×
“In addition, the tumorigenicity of the LDH-A-deficient cells is severely diminished and their respiration rate is increased by 50–60%; this phenotype is reversed by complementation with the human ortholog LDH-A protein [63].”
Background
Research works printed but not linked: 126
- 10.1126/science.123.3191.309 · DOI · Paper page
- 10.1111/j.1742-4658.2007.05686.x · DOI · Paper page
- Reske S. N., 1997, Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma, J. Nucl. Med., 38, 1344
- 10.4067/S0716-97602002000100004 · DOI · Paper page
- Noguchi Y., 1999, Expression of facilitative glucose transporters in gastric tumors, Hepatogastroenterology, 46, 2683
- 10.1677/joe.0.1820467 · DOI
- 10.1016/j.mce.2008.05.003 · DOI
- 10.1002/jcp.21166 · DOI
- Yeh C. S., 2008, Significance of the glycolytic pathway and glycolysis related‐genes in tumorigenesis of human colorectal cancers, Oncol. Rep., 19, 81
- 10.1111/j.1742-4658.2006.05214.x · DOI · Paper page
- 10.1016/0014-2964(78)90177-9 · DOI
- 10.1111/j.1349-7006.2007.00683.x · DOI
- 10.1080/02841850802482486 · DOI
- Vora S., 1985, Alterations in the activity and isozymic profile of human phosphofructokinase durig malignant transformation in vivo and in vitro: Transformation‐and progression‐linked discriminants of malignancy, Cancer Res., 45, 2993
- 10.1002/1097-0142(19910415)67:8<2153::AID-CNCR2820670825>3.0.CO;2-Z · doi:10.1002/1097-0142(19910415)67:8<2153::aid-cncr2820670825>3.0.co;2-z
- 10.1002/pmic.200401022 · DOI · Paper page
- 10.1158/1078-0432.CCR-06-0324 · DOI · Paper page
- Mikuriya K., 2007, Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidence by proteonomic profiling by two‐dimensional electrophoresis, Int. J. Oncol., 30, 849
- 10.1093/carcin/23.5.759 · DOI · Paper page
- 10.1038/sj.bjc.6603377 · DOI · Paper page
- 10.1073/pnas.0700690104 · DOI · Paper page
- 10.1038/sj.onc.1209604 · DOI · Paper page
- 10.1016/S1383-5742(01)00053-9 · DOI · Paper page
- 10.2174/1566524033361645 · DOI · Paper page
- Balinsky D., 1984, Enzyme activities in normal, dysplastic, and cancerous human breast tissues, J. Natl. Cancer. Inst., 72, 217
- 10.1016/j.semradonc.2004.04.004 · DOI · Paper page
- 10.1016/j.ygeno.2004.08.010 · DOI · Paper page
- 10.1074/jbc.M801765200 · DOI · Paper page
- 10.1016/j.ccr.2006.10.020 · DOI · Paper page
- 10.1074/jbc.C000023200 · DOI · Paper page
- 10.1042/BST0350305 · DOI
- 10.1128/MCB.25.14.6225-6234.2005 · DOI · Paper page
- 10.1038/sj.bjc.6601338 · DOI
- 10.1074/jbc.M211195200 · DOI
- 10.1038/sj.onc.1202746 · DOI · Paper page
- Robey I. F., 2008, Regulation of the Warburg effect in early‐passage breast cancer cells, Mol. Cell. Biol., 27, 7381
- 10.1042/bj1540449 · DOI · Paper page
- 10.1042/bj2340169 · DOI
- 10.1042/bj2600763 · DOI
- 10.1016/S0021-9258(18)47278-X · DOI · Paper page
- 10.1073/pnas.93.5.1847 · DOI · Paper page
- 10.1016/S0959-8049(00)00371-3 · DOI
- 10.1309/4KYNQM5862JW2GD7 · doi:10.1309/4kynqm5862jw2gd7 · Paper page
- 10.1016/S0005-2728(02)00248-7 · DOI · Paper page
- Geschwind J. F., 2002, Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production, Cancer Res., 62, 3909
- 10.1158/0008-5472.CAN-04-4313 · DOI
- 10.1042/BJ20080805 · DOI · Paper page
- 10.1002/mnfr.200700470 · DOI · Paper page
- 10.1016/S0014-5793(97)00496-1 · DOI
- 10.1042/bj2510677 · DOI · Paper page
- 10.1006/bbrc.2000.2681 · DOI
- Oskam R., 1985, Isozymic composition and regulatory properties of phosphofructokinase from well‐differentiated and anaplastic medullary thyroid carcinomas of the rat, Cancer Res., 45, 135
- Staal G. E. J., 1987, Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas, Cancer Res., 47, 5047
- 10.1007/s10585-005-2343-7 · DOI · Paper page
- Sonveaux P., 2008, Targeting lactate‐fueled respiration selectively kills hypoxic tumor cells in mice, J. Clin. Invest., 118, 3930
- 10.1159/000401202 · DOI · Paper page
- 10.4161/auto.2229 · DOI · Paper page
- 10.1080/15216540701509955 · DOI · Paper page
- Grogg K. L., 2002, Bronchial carcinoid tumor with crystalloid cytoplasmic inclusions, Arch. Pathol. Lab. Med., 126, 93, 10.5858/2002-126-0093-BCTWCC · doi:10.5858/2002-126-0093-bctwcc
- Morton R., 1976, Alteration of mitochondrial function and lipid composition in Morris 7777 hepatoma, Cancer Res., 36, 3246
- 10.1038/sj.bjc.6603886 · DOI · Paper page
- 10.1038/sj.onc.1209607 · DOI · Paper page
- 10.1038/nrc1737 · DOI · Paper page
- 10.1016/j.abb.2007.02.033 · DOI · Paper page
- 10.1002/pros.20617 · DOI
- 10.1016/j.taap.2006.02.005 · DOI
- 10.1042/bj3640309 · DOI · Paper page
- 10.1186/1476-4598-5-14 · DOI · Paper page
- 10.1016/j.bbamem.2007.02.018 · DOI
- 10.1016/j.bbamem.2007.12.013 · DOI
- Rofstad E. R., 2000, Vascular endothelial growth factor, interleukin 8, platelet‐derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts, Cancer Res., 60, 4932
- 10.1016/0925-4439(94)90085-X · DOI
- 10.1016/S0360-3016(98)00020-0 · DOI
- 10.1016/j.ijrobp.2007.04.067 · DOI
- Vaupel P., 1991, Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancer by computerized O2 tension measurements, Cancer Res., 51, 3316
- Erickson K., 2003, Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation, Cancer Res., 63, 4705
- Kolstad P., 1968, Intercapillary distance, oxygen tension and local recurrence in cervix cancer, Scand. J. Clin. Lab. Invest. Suppl., 196, 145, 10.1080/00365516809168210 · DOI · Paper page
- Kallinowski F., 1989, Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts, Cancer Res., 49, 3759
- 10.1002/(SICI)1099-1492(199605)9:3<125::AID-NBM405>3.0.CO;2-F · DOI
- 10.1667/0033-7587(2001)156[0510:TODWRT]2.0.CO;2 · DOI
- 10.1529/biophysj.106.099135 · DOI
- 10.1016/0006-3002(62)91158-7 · DOI
- 10.1242/jeb.201.8.1129 · DOI · Paper page
- 10.1152/ajpcell.00286.2004 · DOI
- 10.1042/bj3130809 · DOI · Paper page
- 10.1046/j.1471-4159.2001.00214.x · DOI · Paper page
- 10.1111/j.1432-1033.1986.tb10496.x · DOI · Paper page
- 10.1016/j.bbrc.2003.11.136 · DOI · Paper page
- Nakashima R. A., 1984, Contributions of glycolysis and oxidative phosphorylation to adenosine 5′‐triphosphate production in AS‐30D hepatoma cells, Cancer Res., 44, 5702
- Fell D., 1997, Understanding the control of metabolism
- 10.1155/2008/597913 · DOI · Paper page
- 10.1006/abbi.1999.1582 · DOI
- 10.1007/s11060-004-6404-6 · DOI · Paper page
- 10.1002/jcb.21280 · DOI · Paper page
- Newell K. J., 1989, Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide‐3‐chlorophenylhydrazone, Cancer Res., 49, 4477
- 10.1002/jcp.21392 · DOI · Paper page
- Murphy B. J., 1993, Enhancement of heme oxygenase expression and activity in A431 squamous carcinoma multicellular tumor spheroids, Cancer Res., 53, 2700
- 10.1016/0014-4827(91)90140-P · DOI
- 10.1002/cbf.290100110 · DOI
- 10.1002/pmic.200300796 · DOI
- Walenta S., 2000, High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers, Cancer Res., 60, 916
- Peng S. Y., 2008, Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis, Oncol. Rep., 19, 1045
- 10.1002/jcp.1041030121 · doi:10.1002/jcp.1041030121
- 10.1038/sj.onc.1209602 · DOI
- 10.1046/j.1365-2141.1996.d01-1951.x · doi:10.1046/j.1365-2141.1996.d01-1951.x
- 10.1096/fj.02-0541com · DOI · Paper page
- Koya K., 1996, MKT‐077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation, Cancer Res., 56, 538
- 10.1006/abbi.1994.1122 · DOI
- 10.1016/S0006-2952(00)00513-X · DOI
- 10.2174/1568009043332943 · DOI
- 10.1016/S0969-8051(00)00177-3 · DOI
- 10.1146/annurev.med.53.082901.104028 · DOI · Paper page
- 10.2174/1568009043332943 · DOI
- 10.3348/kjr.2006.7.1.57 · DOI · Paper page
- Kubota R., 1994, Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine‐18‐ fluorodeoxyglucose uptake, J. Nucl. Med., 35, 104
- Higashi K., 1998, Fluorine‐18‐FDG PET imaging is negative in bronchioloalveolar lung carcinoma, J. Nucl. Med., 39, 1016
- Han H. S., 2009, High incidence of false positive PET scans in patients with aggressive non‐Hodgkins lymphoma treated with rituximab‐containing regimens, Ann. Oncol., 2, 309, 10.1093/annonc/mdn629 · DOI
- 10.1007/s10147-006-0595-0 · DOI
- Torizuka T., 1995, In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG/PET, J. Nucl. Med., 36, 1811
- 10.1097/01.mnm.0000136693.94761.5c · doi:10.1097/01.mnm.0000136693.94761.5c
- 10.1007/s00259-006-0175-6 · DOI
- 10.1007/s10350-008-9420-3 · DOI · Paper page
- 10.1007/BF03165001 · doi:10.1007/bf03165001
- 10.1053/j.semnuclmed.2005.09.001 · DOI
- 10.1038/sj.pcan.4500879 · DOI · Paper page
- 10.1001/jama.293.5.615 · DOI
Cited by
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K., Tondera, D., Gounarides, J., Yin, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 528
Yoshida, S., Tsutsumi, S., Muhlebach, G., Sourbier, C., Lee, M.-J., Lee, S., Vartholomaiou, E., Tatokoro, M., Beebe, K., Miyajima, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220659110 · Cited by 279
Metadata
- Authors
- Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Saavedra, E., Marín‐Hernández, A., & Gallardo‐Pérez, J. C.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2009-03
- Volume
- 35
- Issue
- 2
- Pages
- 209-225
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W1996447891
- Cited by
- 129
- References
- 23
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? https://app.cochat.ai/papers/10.1002/biof.31
- The paper
- Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Saavedra, E., Marín‐Hernández, A., & Gallardo‐Pérez, J. C. (2009). The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? BioFactors. https://doi.org/10.1002/biof.31
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.